First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

JOURNAL ARTICLE published March 2022 in BioDrugs

Authors: Maxime Boussageon | Aurélie Swalduz | Christos Chouaïd | Olivier Bylicki